Cyclacel Pharmaceuticals, Inc.

NASDAQ (USD): Cyclacel Pharmaceuticals, Inc. (CYCC)

Last Price

0.45

Today's Change

-0.01 (2.17%)

Day's Change

0.358 - 0.46

Trading Volume

4,560,832

Profile
CYCC

Exchange:  NASDAQ Capital Market NASDAQ Capital Market

Currency:  USD USD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Mr. Spiro George Rombotis Mr. Spiro George Rombotis

Full Time Employees:  12 12

IPO Date:  2004-03-16 2004-03-16

CIK:  0001130166 0001130166

ISIN:  US23254L8019 US23254L8019

CUSIP:  23254L603 23254L603

Beta:  0.56 0.56

Last Dividend:  0.00 0.00

Dcf Diff:  0.62 0.62

Dcf:  1.62 1.62

Description

Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combination with venetoclax to treat relapsed or refractory chronic lymphocytic leukemia; and CYC140, a polo-like kinase inhibitor program, which is in Phase 1/2 clinical trial for the treatment of advanced leukemias and solid tumors. Its development programs also comprise Sapacitabine, a novel nucleoside analog that is orally available prodrug of CNDAC, which is in Phase 1/2 clinical trials to treat acute myeloid leukemia and myelodysplastic syndrome; and seliciclib, a CDK inhibitor that is in Phase 2 investigator-sponsored trials (IST) for Cushing's disease, as well as in Phase 1/2 IST for the treatment for advanced rheumatoid arthritis. The company has a clinical collaboration agreement with the University of Texas MD Anderson Cancer Center to clinically evaluate the safety and efficacy of three cyclacel medicines in patients with hematological malignancies, including chronic lymphocytic leukemias, acute myeloid leukemias, myelodysplastic syndromes, and other advanced leukemias. Cyclacel Pharmaceuticals, Inc. is headquartered in Berkeley Heights, New Jersey.

Address

200 Connell Drive,
Berkeley Heights, NJ 07922, US

908 517 7330

http://www.cyclacel.com

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment